$AIMT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aimmune Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aimmune Therapeutics, Inc.. Get notifications about new insider transactions in Aimmune Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | A | 23.81 | 52,500 | 1,250,025 | 52,500 | |
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Grant | A | 0.00 | 8,750 | 0 | 29,167 | 20.4 K to 29.2 K (+42.86 %) |
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Option Exercise | A | 23.81 | 67,500 | 1,607,175 | 67,500 | |
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Grant | A | 0.00 | 11,250 | 0 | 23,250 | 12 K to 23.3 K (+93.75 %) |
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | A | 23.81 | 67,500 | 1,607,175 | 67,500 | |
Mar 03 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Grant | A | 0.00 | 11,250 | 0 | 56,918 | 68.2 K to 56.9 K (-16.50 %) |
Jan 21 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 400 | 5,180 | 53,249 | |
Jan 21 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 37.00 | 400 | 14,800 | 45,668 | 46.1 K to 45.7 K (-0.87 %) |
Jan 21 2020 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 400 | 5,180 | 46,068 | 45.7 K to 46.1 K (+0.88 %) |
Jan 03 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 19.63 | 20,000 | 392,600 | 70,000 | |
Jan 03 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 35.00 | 20,000 | 700,038 | 21,250 | 41.3 K to 21.3 K (-48.48 %) |
Jan 03 2020 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 19.63 | 20,000 | 392,600 | 41,250 | 21.3 K to 41.3 K (+94.12 %) |
Dec 30 2019 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 10,000 | 129,500 | 53,649 | |
Dec 30 2019 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 33.03 | 10,000 | 330,322 | 45,668 | 55.7 K to 45.7 K (-17.96 %) |
Dec 30 2019 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 10,000 | 129,500 | 55,668 | 45.7 K to 55.7 K (+21.90 %) |
Dec 11 2019 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 20,000 | 229,000 | 170,000 | |
Dec 11 2019 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 30.04 | 20,000 | 600,716 | 21,250 | 41.3 K to 21.3 K (-48.48 %) |
Dec 11 2019 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 20,000 | 229,000 | 41,250 | 21.3 K to 41.3 K (+94.12 %) |
Sep 20 2019 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 22.57 | 1,550 | 34,977 | 33,574 | 32 K to 33.6 K (+4.84 %) |
Sep 20 2019 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 22.57 | 1,550 | 34,977 | 33,574 | 32 K to 33.6 K (+4.84 %) |
Sep 19 2019 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Grant | A | 22.34 | 12,500 | 279,216 | 45,561 | 33.1 K to 45.6 K (+37.81 %) |
May 28 2019 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | A | 19.90 | 11,432 | 227,497 | 11,432 | |
May 28 2019 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Grant | A | 0.00 | 6,442 | 0 | 10,192 | 3.8 K to 10.2 K (+171.79 %) |
May 28 2019 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | A | 19.90 | 11,432 | 227,497 | 11,432 | |
May 28 2019 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Grant | A | 0.00 | 6,442 | 0 | 26,852 | 20.4 K to 26.9 K (+31.56 %) |
May 28 2019 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | A | 19.90 | 11,432 | 227,497 | 11,432 | |
May 28 2019 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 6,442 | 0 | 65,192 | 58.8 K to 65.2 K (+10.97 %) |
May 28 2019 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Gift | G | 0.00 | 69,894 | 0 | 69,894 | 0 to 69.9 K |
May 28 2019 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Gift | G | 0.00 | 69,894 | 0 | 58,750 | 128.6 K to 58.8 K (-54.33 %) |
May 28 2019 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | A | 19.90 | 11,432 | 227,497 | 11,432 | |
May 28 2019 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Grant | A | 0.00 | 6,442 | 0 | 10,221 | 3.8 K to 10.2 K (+170.47 %) |
May 28 2019 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 19.90 | 11,432 | 227,497 | 11,432 | |
May 28 2019 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 6,442 | 0 | 33,061 | 26.6 K to 33.1 K (+24.20 %) |
May 28 2019 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | A | 19.90 | 11,432 | 227,497 | 11,432 | |
May 28 2019 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Grant | A | 0.00 | 6,442 | 0 | 39,567 | 33.1 K to 39.6 K (+19.45 %) |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | A | 23.72 | 75,000 | 1,779,000 | 75,000 | |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Grant | A | 0.00 | 12,500 | 0 | 45,668 | 33.2 K to 45.7 K (+37.69 %) |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | A | 23.72 | 71,250 | 1,690,050 | 71,250 | |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Grant | A | 0.00 | 11,875 | 0 | 21,250 | 9.4 K to 21.3 K (+126.67 %) |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 23.72 | 78,750 | 1,867,950 | 78,750 | |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 13,125 | 0 | 32,857 | 19.7 K to 32.9 K (+66.52 %) |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | A | 23.72 | 45,000 | 1,067,400 | 45,000 | |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Grant | A | 0.00 | 7,500 | 0 | 14,504 | 7 K to 14.5 K (+107.08 %) |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | A | 23.72 | 210,000 | 4,981,200 | 210,000 | |
Feb 26 2019 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Grant | A | 0.00 | 35,000 | 0 | 98,650 | 63.7 K to 98.7 K (+54.99 %) |
Jan 24 2019 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Option Exercise | A | 21.94 | 150,000 | 3,291,000 | 150,000 | |
Jan 24 2019 | AIMT | Aimmune Therapeuti ... | Oxtoby Andrew | Chief Commercial Of ... | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
Nov 21 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 40,000 | 120,880 | 53,400 | |
Nov 21 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 30.04 | 40,000 | 1,201,600 | 9,375 | 49.4 K to 9.4 K (-81.01 %) |
Nov 21 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 40,000 | 120,880 | 49,375 | 9.4 K to 49.4 K (+426.67 %) |
Nov 19 2018 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Buy | P | 27.56 | 50 | 1,378 | 63,650 | 63.6 K to 63.7 K (+0.08 %) |
Nov 19 2018 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Buy | P | 27.56 | 3,600 | 99,209 | 63,600 | 60 K to 63.6 K (+6.00 %) |
Jun 19 2018 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Option Exercise | A | 30.68 | 350,000 | 10,738,000 | 350,000 | |
Jun 19 2018 | AIMT | Aimmune Therapeuti ... | Dallas Jayson Donald Alexander | President and CEO | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
Jun 14 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 30.41 | 1,600 | 48,663 | 19,485 | 17.9 K to 19.5 K (+8.95 %) |
Jun 13 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Option Exercise | M | 3.02 | 29,457 | 89,022 | 295,942 | |
Jun 13 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 30.83 | 29,457 | 908,301 | 315,308 | 344.8 K to 315.3 K (-8.54 %) |
Jun 13 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Buy | M | 3.02 | 29,457 | 89,022 | 344,765 | 315.3 K to 344.8 K (+9.34 %) |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Option Exercise | M | 3.02 | 42,106 | 127,249 | 325,399 | |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Option Exercise | M | 3.02 | 32,598 | 98,514 | 367,505 | |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Option Exercise | M | 3.02 | 30,465 | 92,068 | 400,103 | |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 30.70 | 42,106 | 1,292,511 | 315,308 | 357.4 K to 315.3 K (-11.78 %) |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Buy | M | 3.02 | 42,106 | 127,249 | 357,414 | 315.3 K to 357.4 K (+13.35 %) |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 31.58 | 500 | 15,790 | 315,308 | 315.8 K to 315.3 K (-0.16 %) |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 30.95 | 32,098 | 993,321 | 315,808 | 347.9 K to 315.8 K (-9.23 %) |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Buy | M | 3.02 | 32,598 | 98,514 | 347,906 | 315.3 K to 347.9 K (+10.34 %) |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Sell | S | 31.20 | 30,465 | 950,371 | 315,308 | 345.8 K to 315.3 K (-8.81 %) |
Jun 08 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | President and CEO | Buy | M | 3.02 | 30,465 | 92,068 | 345,773 | 315.3 K to 345.8 K (+9.66 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Option Exercise | M | 3.02 | 38,825 | 117,333 | 430,568 | |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Option Exercise | M | 3.02 | 65,352 | 197,500 | 469,393 | |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Option Exercise | M | 3.02 | 61,197 | 184,943 | 534,745 | |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 31.83 | 38,825 | 1,235,835 | 315,308 | 354.1 K to 315.3 K (-10.96 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Buy | M | 3.02 | 38,825 | 117,333 | 354,133 | 315.3 K to 354.1 K (+12.31 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 32.74 | 2,612 | 85,519 | 315,308 | 317.9 K to 315.3 K (-0.82 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 31.84 | 62,740 | 1,997,836 | 317,920 | 380.7 K to 317.9 K (-16.48 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Buy | M | 3.02 | 65,352 | 197,500 | 380,660 | 315.3 K to 380.7 K (+20.73 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 33.19 | 2,498 | 82,899 | 315,308 | 317.8 K to 315.3 K (-0.79 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Sell | S | 32.59 | 58,699 | 1,913,094 | 317,806 | 376.5 K to 317.8 K (-15.59 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Buy | M | 3.02 | 61,197 | 184,943 | 376,505 | 315.3 K to 376.5 K (+19.41 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 2,438 | 0 | 25,532 | 23.1 K to 25.5 K (+10.56 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 2,438 | 0 | 12,009 | 14.4 K to 12 K (-16.88 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 2,438 | 0 | 23,094 | 20.7 K to 23.1 K (+11.80 %) |
Jun 05 2018 | AIMT | Aimmune Therapeuti ... | DILLY STEPHEN GEORGE | See Remarks | Gift | G | 0.00 | 2,438 | 0 | 12,009 | 14.4 K to 12 K (-16.88 %) |
May 24 2018 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 32.79 | 7,500 | 245,925 | 7,500 | |
May 24 2018 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 3,750 | 0 | 26,619 | 22.9 K to 26.6 K (+16.40 %) |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 1,648 | 21,342 | 63,649 | |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 1,648 | 21,342 | 65,297 | |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 33.00 | 1,648 | 54,384 | 33,079 | 34.7 K to 33.1 K (-4.75 %) |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 1,648 | 21,342 | 34,727 | 33.1 K to 34.7 K (+4.98 %) |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 33.00 | 1,648 | 54,384 | 33,079 | 34.7 K to 33.1 K (-4.75 %) |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 1,648 | 21,342 | 34,727 | 33.1 K to 34.7 K (+4.98 %) |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Option Exercise | A | 32.79 | 7,500 | 245,925 | 7,500 | |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Seltzer Stacey Denenberg | Director | Grant | A | 0.00 | 3,750 | 0 | 3,779 | 29 to 3.8 K (+12,931.03 %) |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Option Exercise | A | 32.79 | 7,500 | 245,925 | 7,500 | |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Behar Gregory | Director | Grant | A | 0.00 | 3,750 | 0 | 3,750 | 0 to 3.8 K |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Option Exercise | A | 32.79 | 7,500 | 245,925 | 7,500 | |
May 24 2018 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Grant | A | 0.00 | 3,750 | 0 | 33,125 | 29.4 K to 33.1 K (+12.77 %) |
May 24 2018 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Option Exercise | A | 32.79 | 7,500 | 245,925 | 7,500 | |
May 24 2018 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 3,750 | 0 | 128,644 | 124.9 K to 128.6 K (+3.00 %) |
May 24 2018 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Option Exercise | A | 32.79 | 7,500 | 245,925 | 7,500 | |
May 24 2018 | AIMT | Aimmune Therapeuti ... | MCDADE MARK | Director | Grant | A | 0.00 | 3,750 | 0 | 20,410 | 16.7 K to 20.4 K (+22.51 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Grant | A | 0.00 | 9,375 | 0 | 9,375 | 0 to 9.4 K |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Grant | A | 0.00 | 9,375 | 0 | 12,151 | 2.8 K to 12.2 K (+337.72 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | A | 34.07 | 41,250 | 1,405,388 | 41,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Grant | A | 0.00 | 6,875 | 0 | 7,004 | 129 to 7 K (+5,329.46 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 1,648 | 21,342 | 66,945 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 19.63 | 1,875 | 36,806 | 67,500 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | A | 34.07 | 75,000 | 2,555,250 | 75,000 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 36.60 | 700 | 25,618 | 32,500 | 33.2 K to 32.5 K (-2.11 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 35.52 | 948 | 33,674 | 33,200 | 34.1 K to 33.2 K (-2.78 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 1,648 | 21,342 | 34,148 | 32.5 K to 34.1 K (+5.07 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 37.00 | 1,875 | 69,375 | 32,500 | 34.4 K to 32.5 K (-5.45 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 19.63 | 1,875 | 36,806 | 34,375 | 32.5 K to 34.4 K (+5.77 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Grant | A | 0.00 | 32,500 | 0 | 32,500 | 0 to 32.5 K |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Grant | A | 0.00 | 9,375 | 0 | 9,375 | 0 to 9.4 K |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 9,375 | 0 | 17,500 | 8.1 K to 17.5 K (+115.38 %) |
Mar 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 1,807 | 5,461 | 105,436 | |
Mar 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 33.10 | 1,807 | 59,812 | 129 | 1.9 K to 129 (-93.34 %) |
Mar 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 1,807 | 5,461 | 1,936 | 129 to 1.9 K (+1,400.78 %) |
Feb 26 2018 | AIMT | Aimmune Therapeuti ... | Tammenoms Bakker Juliet | 10% Owner | Buy | P | 32.00 | 9,375 | 300,000 | 16,651 | 7.3 K to 16.7 K (+128.85 %) |
Feb 26 2018 | AIMT | Aimmune Therapeuti ... | ENRIGHT PATRICK G | Director | Buy | P | 32.00 | 15,593 | 498,976 | 22,869 | 7.3 K to 22.9 K (+214.31 %) |
Feb 26 2018 | AIMT | Aimmune Therapeuti ... | Iwicki Mark T | Director | Buy | P | 32.00 | 9,375 | 300,000 | 29,375 | 20 K to 29.4 K (+46.88 %) |
Feb 26 2018 | AIMT | Aimmune Therapeuti ... | FALBERG KATHRYN E | Director | Buy | P | 32.00 | 30,000 | 960,000 | 124,894 | 94.9 K to 124.9 K (+31.61 %) |
Feb 26 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Buy | P | 32.00 | 3,125 | 100,000 | 8,125 | 5 K to 8.1 K (+62.50 %) |
Feb 07 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 1,648 | 21,342 | 68,593 | |
Feb 07 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 35.87 | 1,648 | 59,114 | 0 | 1.6 K to 0 (-100.00 %) |
Feb 07 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 1,648 | 21,342 | 1,648 | 0 to 1.6 K |
Feb 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 6,592 | 19,921 | 107,243 | |
Feb 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 35.58 | 4,292 | 152,703 | 129 | 4.4 K to 129 (-97.08 %) |
Feb 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 34.95 | 2,300 | 80,385 | 4,421 | 6.7 K to 4.4 K (-34.22 %) |
Feb 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 6,592 | 19,921 | 6,721 | 129 to 6.7 K (+5,110.08 %) |
Jan 26 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 19.63 | 1,875 | 36,806 | 69,375 | |
Jan 26 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 38.15 | 1,875 | 71,531 | 0 | 1.9 K to 0 (-100.00 %) |
Jan 26 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 19.63 | 1,875 | 36,806 | 1,875 | 0 to 1.9 K |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 9,933 | 113,733 | 190,000 | |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | M | 11.45 | 26,784 | 306,677 | 199,933 | |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 40.00 | 9,933 | 397,320 | 0 | 9.9 K to 0 (-100.00 %) |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 9,933 | 113,733 | 9,933 | 0 to 9.9 K |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Sell | S | 40.00 | 26,784 | 1,071,360 | 0 | 26.8 K to 0 (-100.00 %) |
Jan 16 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Buy | M | 11.45 | 26,784 | 306,677 | 26,784 | 0 to 26.8 K |
Jan 08 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 1,648 | 21,342 | 70,241 | |
Jan 08 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 37.33 | 1,648 | 61,520 | 0 | 1.6 K to 0 (-100.00 %) |
Jan 08 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 1,648 | 21,342 | 1,648 | 0 to 1.6 K |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 6,591 | 19,918 | 113,835 | |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 37.08 | 1,601 | 59,367 | 129 | 1.7 K to 129 (-92.54 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 37.12 | 4,990 | 185,223 | 1,730 | 6.7 K to 1.7 K (-74.26 %) |